149 related articles for article (PubMed ID: 9533973)
1. Autonomic correlates of antidepressant treatment using heart-rate variability analysis.
Khaykin Y; Dorian P; Baker B; Shapiro C; Sandor P; Mironov D; Irvine J; Newman D
Can J Psychiatry; 1998 Mar; 43(2):183-6. PubMed ID: 9533973
[TBL] [Abstract][Full Text] [Related]
2. Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder.
Baker B; Dorian P; Sandor P; Shapiro C; Schell C; Mitchell J; Irvine MJ
J Clin Psychopharmacol; 1997 Feb; 17(1):15-21. PubMed ID: 9004052
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
[TBL] [Abstract][Full Text] [Related]
4. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
[TBL] [Abstract][Full Text] [Related]
5. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.
Nelson JC; Mazure CM; Jatlow PI; Bowers MB; Price LH
Biol Psychiatry; 2004 Feb; 55(3):296-300. PubMed ID: 14744472
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
[TBL] [Abstract][Full Text] [Related]
7. Antidepressants strongly influence the relationship between depression and heart rate variability: findings from The Irish Longitudinal Study on Ageing (TILDA).
O'Regan C; Kenny RA; Cronin H; Finucane C; Kearney PM
Psychol Med; 2015 Feb; 45(3):623-36. PubMed ID: 25075912
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression.
Bech P; Cialdella P; Haugh MC; Birkett MA; Hours A; Boissel JP; Tollefson GD
Br J Psychiatry; 2000 May; 176():421-8. PubMed ID: 10912216
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders].
Cvjetković-Bosnjak M; Knezević A; Soldatović-Stajić B
Med Pregl; 1999; 52(3-5):108-11. PubMed ID: 10518394
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine versus other types of pharmacotherapy for depression.
Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
Sun Y; Liang Y; Jiao Y; Lin J; Qu H; Xu J; Zhao C
BMJ Open; 2017 Aug; 7(8):e016499. PubMed ID: 28775189
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of initial antidepressant drug choice in a "real world" randomized trial.
Simon GE; Heiligenstein J; Revicki D; VonKorff M; Katon WJ; Ludman E; Grothaus L; Wagner E
Arch Fam Med; 1999; 8(4):319-25. PubMed ID: 10418538
[TBL] [Abstract][Full Text] [Related]
13. Compliance with antidepressant medication in the treatment of major depressive disorder in primary care: a randomized comparison of fluoxetine and a tricyclic antidepressant.
Thompson C; Peveler RC; Stephenson D; McKendrick J
Am J Psychiatry; 2000 Mar; 157(3):338-43. PubMed ID: 10698807
[TBL] [Abstract][Full Text] [Related]
14. Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination?
Levitt AJ; Joffe RT; Kamil R; McIntyre R
J Clin Psychiatry; 1999 Sep; 60(9):613-6. PubMed ID: 10520980
[TBL] [Abstract][Full Text] [Related]
15. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine: new indication. Depression in children: too many uncertainties.
Prescrire Int; 2008 Oct; 17(97):186-7. PubMed ID: 19534039
[No Abstract] [Full Text] [Related]
17. Cardiovascular effects of fluoxetine in depressed patients with heart disease.
Roose SP; Glassman AH; Attia E; Woodring S; Giardina EG; Bigger JT
Am J Psychiatry; 1998 May; 155(5):660-5. PubMed ID: 9585718
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.
Wong ML; Dong C; Flores DL; Ehrhart-Bornstein M; Bornstein S; Arcos-Burgos M; Licinio J
Am J Psychiatry; 2014 Dec; 171(12):1297-309. PubMed ID: 25220861
[TBL] [Abstract][Full Text] [Related]
19. Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning.
Dubini A; Bosc M; Polin V
J Psychopharmacol; 1997; 11(4 Suppl):S17-23. PubMed ID: 9438229
[TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.
Costa e Silva J
J Clin Psychiatry; 1998 Jul; 59(7):352-7. PubMed ID: 9714263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
